MediWound Ltd.
11.56%
1,481,521
1593984
M68830112
Sep 29, 2025
Oct 3, 2025, 09:30 PM
Reporting Persons (7)
This is a joint filing. The reported shares may overlap between reporting persons and should not be summed.
| Name | Type | % of Class | Aggregate | Sole Voting | Shared Voting |
|---|---|---|---|---|---|
| Clal Industries Ltd. | CO | 11.56% | 1,481,521 | 0 | 1,481,521 |
| Access Industries, LLC | Other | 11.56% | 1,481,521 | 0 | 1,481,521 |
| Access Industries Management, LLC | Other | 11.56% | 1,481,521 | 0 | 1,481,521 |
| Access Industries Holdings LLC | Other | 11.56% | 1,481,521 | 0 | 1,481,521 |
| Clal Biotechnology Industries Ltd. | CO | 11.56% | 1,481,521 | 308,811 | 1,172,710 |
| Len Blavatnik | Individual | 11.56% | 1,481,521 | 0 | 1,481,521 |
| Clal Life Sciences L.P. | Partnership | 9.15% | 1,172,710 | 1,172,710 | 0 |
Disclosure Items (3)
Ordinary Shares, par value NIS 0.07 per share
MediWound Ltd.
42 Hayarkon Street, Yavne, L3, 8122745
Items 5(a) and (b) to the Schedule are hereby amended and restated as follows: (a) and (b) The responses of each of the Reporting Persons with respect to Rows 11, 12, and 13 of the cover pages of this Schedule 13D that relate to the aggregate number and percentage of ordinary shares, par value NIS 0.07 per share (the "Ordinary Shares") (including but not limited to footnotes to such information) are incorporated herein by reference.
The responses of each of the Reporting Persons with respect to Rows 7, 8, 9, and 10 of the cover pages of this Schedule 13D that relate to the number of Ordinary Shares as to which each of the persons or entities referenced in Item 2 above has sole or shared power to vote or to direct the vote of and sole or shared power to dispose of or to direct the disposition of (including but not limited to footnotes to such information) are incorporated herein by reference.
CBI owns directly 308,811 Ordinary Shares, and may be deemed to share voting and investment power over the 1,172,710 Ordinary Shares owned directly by CLS, the general partner of which, Clal Application Center Ltd., is wholly owned by CBI. CBI is a publicly traded company traded on the Tel Aviv Stock Exchange. Each of AIH, Access LLC, AIM, Clal Industries and Mr. Blavatnik may be deemed to share voting and investment power over the Ordinary Shares owned directly by CBI and CLS because (i) Len Blavatnik controls AIM, AIH, Access LLC and AI International GP Limited (the general partner of AI SMS, as defined below), (ii) AIM controls Access LLC and AIH, (iii) Access LLC controls a majority of the outstanding voting interests in AIH, (iv) AIH owns a majority of the equity of AI SMS L.P. ("AI SMS"), (v) AI SMS controls AI Diversified Holdings Ltd. ("Holdings Limited"), (vi) Holdings Limited owns AI Diversified Parent S.a r.l., which owns AI Diversified Holdings S.a r.l., which owns Access AI Ltd ("Access AI"), (vii) Access AI wholly owns Clal Industries, (viii) Clal Industries is the controlling shareholder of CBI, and (ix) CBI is the sole shareholder of Clal Application Center Ltd. The Reporting Persons, other than CBI and CLS, and each of their affiliated entities and the officers, partners, members and managers thereof, disclaims beneficial ownership of these securities.
Exhibit 99.3 Joint Filing Agreement (incorporated by reference to Exhibit 99.2 to Schedule 13D/A filed with the SEC on September 1, 2023).